By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Orphan Therapeutics, LLC 

3 Werner Way, Suite 300

Lebanon  New Jersey  08833  U.S.A.
Phone: 908-849-4805 Fax: 908-849-4806


Company News
Ikaria Holdings: FDA Accepts Final Section of NDA Filing for LUCASSIN(R) 6/12/2009 8:38:00 AM
Ikaria Inc. Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics, LLC 9/2/2008 10:08:26 AM
Orphan Therapeutics, LLC Announces Initiation of Rolling NDA Submission for LUCASSIN(R) (terlipressin) for the Treatment of Hepatorenal Syndrome Type 1 5/28/2008 10:58:52 AM
PDL BioPharma, Inc. (PDLI) And Orphan Therapeutics, LLC End Collaboration Agreement For Terlipressin 12/19/2006 1:02:07 PM
Orphan Therapeutics, LLC Announces Rolling NDA Submission For LUCASSIN(TM) (terlipressin) To Treat Type 1 Hepatorenal Syndrome 12/18/2006 1:39:00 PM
Jazz Pharmaceuticals, Inc. To Buy Orphan Medical, Inc. (ORPH) For About $122.6 Million In Cash10/19/2005 5:13:08 PM
Protein Design Labs, Inc. (PDLI) And Orphan Therapeutics, LLC Report Fast Track Designation For Terlipressin In Type 1 Hepatorenal Syndrome10/19/2005 5:13:02 PM